# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 08-11-2025 | 06-30-2025 | 10-Q | |
2 | 05-12-2025 | 03-31-2025 | 10-Q | |
3 | 03-26-2025 | 12-31-2024 | 10-K | |
4 | 11-12-2024 | 09-30-2024 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
-SEC Filing
Oppenheimer analyst Michael Wiederhorn initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Outperform rating ...
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE: GRDN) with a Buy and raises the price t...
Guardian Pharmacy Service (NYSE:GRDN) raises FY2025 sales outlook from $1.330 billion-$1.350 billion to $1.390 billion-$1.410 b...
Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate ...
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care (LTC) pharmacy services companies,...
Byron Allen dials out, Salesforce logs in. Here are the various deal announcements of the past week plus bankruptcy updates.
Guardian Pharmacy Services acquires Mercury Pharmacy Services in Washington, expanding its presence in the Pacific Northwest a...